RBC Europe’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-920
| Closed | -$17K | – | 632 |
|
2022
Q1 | $17K | Buy |
+920
| New | +$17K | ﹤0.01% | 469 |
|
2021
Q4 | – | Sell |
-1,087
| Closed | -$44.7K | – | 768 |
|
2021
Q3 | $44.7K | Hold |
1,087
| – | – | ﹤0.01% | 596 |
|
2021
Q2 | $61.6K | Buy |
1,087
+920
| +551% | +$52.1K | ﹤0.01% | 546 |
|
2021
Q1 | $7.01K | Sell |
167
-50
| -23% | -$2.1K | ﹤0.01% | 961 |
|
2020
Q4 | $15.2K | Buy |
217
+50
| +30% | +$3.51K | ﹤0.01% | 792 |
|
2020
Q3 | $4.69K | Hold |
167
| – | – | ﹤0.01% | 912 |
|
2020
Q2 | $4.94K | Hold |
167
| – | – | ﹤0.01% | 870 |
|
2020
Q1 | $3.31K | Hold |
167
| – | – | ﹤0.01% | 861 |
|
2019
Q4 | $4.95K | Hold |
167
| – | – | ﹤0.01% | 903 |
|
2019
Q3 | $3.8K | Hold |
167
| – | – | ﹤0.01% | 921 |
|
2019
Q2 | $4.13K | Hold |
167
| – | – | ﹤0.01% | 934 |
|
2019
Q1 | $4.08K | Buy |
+167
| New | +$4.08K | ﹤0.01% | 949 |
|
2018
Q3 | – | Sell |
-865
| Closed | -$31K | – | 1144 |
|
2018
Q2 | $31K | Sell |
865
-118
| -12% | -$4.23K | ﹤0.01% | 581 |
|
2018
Q1 | $32.6K | Hold |
983
| – | – | ﹤0.01% | 567 |
|
2017
Q4 | $30.2K | Hold |
983
| – | – | ﹤0.01% | 591 |
|
2017
Q3 | $23.6K | Buy |
+983
| New | +$23.6K | ﹤0.01% | 649 |
|